Epidemiological and Genetic Characterization of Methicillin-Resistant Staphylococcus aureus Isolates from the Ear Discharge of Outpatients with Chronic Otitis Media by Yang, Jin Ah et al.
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) is a com-
mon hospital pathogen found worldwide. According to the
Korean Nationwide Surveillance of Antimicrobial Resistance
study, the prevalence of MRSA has been reported as 68% of
S. aureus isolates in Korean hospitals (1). Meanwhile, the rate
of MRSA isolates among non-tertiary hospitals has increased
to 46% in 2005 (http://karms.nih. go.kr). 
The emergence of a novel type of S. aureus, community-
acquired (CA) MRSA, has been reported in other parts of
the world. Since it was reported first in the United States in
1995 (2), CA-MRSA has been recognized as another sub-
stantial public health threat caused by S. aureus. CA-MRSA
has not been established yet in Korea, but the recent increas-
ing prevalence of MRSA in outpatient populations has led
to confusion over whether these cases originate from the com-
munity or from the healthcare setting. A substantial pro-
portion of outpatient strains of MRSA come from ear dis-
charge found in otolaryngology practices. However, there is
no published data on the origin of MRSA strains in these
patients in terms of genotypic analysis. 
The genetic basis of the methicillin resistance of MRSA is
the presence of the mecA gene, which encodes the low-affini-
ty penicillin binding protein 2a. This protein is carried by a
mobile genetic element staphylococcal cassette chromosome
mec (SCCmec). Currently, six types of SCCmec (types I to VI)
have been discovered. SCCmec types I, II, and III are associ-
ated with hospital-acquired MRSA, whereas types IV, V, and
VI are associated with CA-MRSA. 
In the outpatient setting, it is difficult to distinguish com-
munity-acquired MRSA from nosocomial MRSA. Based on
epidemiology and past history related to healthcare-associ-
ated risk factors, MRSA could be designated as either com-
munity-acquired, healthcare-associated, or nosocomial in
origin (3). However, the definite designation of MRSA strains
as community-acquired or healthcare-associated requires both
rigorous epidemiological and molecular analyses.
The aim of this study was to use epidemiological and genet-
ic analyses to identify the origins of MRSA isolates from ear
discharge in otolaryngology outpatients with chronic otitis
media. 
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Epidemiological and Genetic Characterization of Methicillin-Resistant
Staphylococcus aureus Isolates from the Ear Discharge of 
Outpatients with Chronic Otitis Media
The origin of methicillin-resistant Staphylococcus aureus (MRSA) strains from oto-
laryngology outpatients has not been evaluated yet in Korea. We analyzed epidemi-
ologic and genetic characteristics of MRSA isolates from the ear discharge of 64
outpatients with chronic otitis media in a Korean University Hospital during 2004.
MRSA strains were grouped as either from the initial visit (n=33) or the follow-up
visit (n=31) based on the timing of isolation. Healthcare-associated risk factors were
frequently present among patients of the initial visit group, especially prior visit to
primary clinic (79%) and antibiotic use (73%). SCCmec typing and multilocus sequ-
ence typing results showed that two genotypes, ST5-MRSA-II and ST239-MRSA-
III,were prevalent in both the initial visit (73% vs. 24%) and the follow-up visit (55%
vs. 42%). Pulsed-field gel electrophoresis identified eight types, including two major
types shared by both groups. We conclude that majority of MRSA strains from ear
discharge of chronic otitis media belonged to nosocomial clones that might be cir-
culating in the community. This is the first report of the genetic analysis of MRSA
strains from otolaryngology practices in Korea.
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MATERIALS AND METHODS
Clinical isolates and antimicrobial susceptibility 
A total of 64 clinical isolates of MRSA were collected bet-
ween January and September 2004 from ear discharge of
otolaryngology outpatients with chronic otitis media in the
750-bed Korea University Anam Hospital. Only the first
isolate per patient was included in the study. Oxacillin resis-
tance was determined by the standard disk diffusion method,
using the guidelines of the Clinical Laboratory Standards
Institutue (CLSI) (4), and confirmed by polymerase chain
reaction (PCR) amplification of the mecA gene (5).
Antimicrobial susceptibility tests were performed by disk
diffusion for penicillin, clindamycin, tetracycline, oxacillin,
erythromycin, cephalothin, ciprofloxacin, and vancomycin,
as recommended by the CLSI (4). 
Data collection 
The following data were collected from patients’ medical
charts and from hospital electronic databases: age, sex, under-
lying disease, dates of initial and follow-up visits, and tim-
ing of the first MRSA isolation. A survey was performed by
a trained nurse on the telephone to determine whether there
was direct or indirect exposure to the healthcare setting within
one year, such as hospitalization, an outpatient visit, antibi-
otic exposure, surgical operations, or close contact with peo-
ple having these risk factors. 
SCCmec typing 
SCCmec types were determined by rapid PCR-restriction
fragment length polymorphism (RFLP) analysis of the ccrB
gene, as described earlier (5). Chromosomal DNA was extract-
ed with a Wizard genomic DNA preparation kit (Promega,
Madison, WI, U.S.A.) using lysostaphin (0.5 mg/mL) and
RNase (0.3 mg/mL). The 643-bp ccrB gene fragment was
amplified using a pair of primers: CRB-1 (5′ -GGC TAT TAT
CAA GGC AAT TTA CC -3′ ), and CRB-2 (5′ -ACT TTA
TCA CTT TTG ACT ATT TCG 3′ ). Thermal cycling was
set at 30 cycles (30 sec for denaturation at 94℃, 1 min for
annealing at 50℃, and 2 min for elongation at 72℃). PCR
products were purified by the QIAquick-spin PCR purifica-
tion kit (Qiagen Inc., Valencia, CA, U.S.A.) and followed by
digestion with HinfI and BsmI (New England Biolabs Inc.,
Ipswich, MA, U.S.A.). The RFLP patterns were analyzed
using 2% agarose gel electrophoresis.
Multilocus sequence typing (MLST)
MLST was performed using the method described by
Enright et al. (6). PCR was performed using chromosomal
DNA and the identical primer sets to amplify fragments of
the following seven housekeeping genes: arcC,aroE,glp,gmk,
pta, tpi, and yqiL. The process was carried out with an initial
denaturation at 95℃for 5 min, followed by 30 cycles of 95℃
for 30 sec, 54℃ for 30 sec, and 72℃ for 1 min. The reac-
tion was then maintained at 72℃ for an additional 5 min.
The amplified fragments were purified using the PCR purifi-
cation kit and then sequenced by Bioneer (Bioneer Co., Dae-
jeon, Korea). The allelic profiles (STs) were determined using
MLST data-base (http://saureus.mlst.net). 
Pulsed-field gel electrophoresis (PFGE)
Chromosomal DNA from S. aureus was prepared in agarose
blocks and was cleaved with SmaI (New England Biolabs
Inc.). Electrophoresis was performed with the GeneNaviga-
tor System (Amersham Pharmacia Biotech, Uppsala, Swe-
den) using 130 V at 16℃; There were a 5 sec pulse time
for 4 hr, a 25-sec pulse time for 6 hr, a 45-sec pulse time for
20 hr, and a 75-sec pulse time for 6 hr. The Lambda Ladder
Standard (New England Biolabs) was used as a size marker.
Band images were captured and analysis of banding patterns
was performed using the Molecular Imager Gel Doc XR sys-
tem (Bio Rad Laboratories, Hercules, CA, U.S.A.) and Quan-
tity One analysis software version 4.6.1 (Bio Rad Laborato-
ries). The similarity among all pairs was assessed using the
Dice coefficient correlation; unweighted pair group method
(UPGMA) clustering was used to construct a dendrogram.
Band patterns of the isolates were compared using criteria
for bacterial strain typing (7). 
RESULTS
Risk factors for MRSA acquisition
During the study period from January 2004 to Septem-
ber 2004, 126 isolates of MRSA were isolated from the out-
patient population in this hospital. Seventy-one of these iso-
lates (57%) were collected from the ear discharge of patients
with chronic otitis media. Sixty-four patients (90%) were
queried for study enrolment and the remaining 7 patients
were unavailable or had an unknown timing of MRSA iso-
lation. Based on the timing of isolation, 34 (52%) subjects
had a positive culture during the initial visit and 31 patients
(49%) had a positive culture during the follow-up visit. It
was unknown whether the MRSA came from colonization
or infection. Routinely screening cultures for MRSA from
all outpatients attending the clinic was impractical due to
financial and other constraints. Therefore, the screening of
cultures for MRSA was performed only in patients with ear
discharge on the initial visit or during the follow-up visit.
The median age of the study population was 47 yr (rang-
ing from 1 to 79 yr), and 61% of participants (39/64) were
female. Risk factors associated with MRSA acquisition were764 J.A. Yang, J.Y. Kim, Y.K. Yoon, et al.
identified in both subject groups with MRSA isolates on
the initial visit and the follow-up visit (Table 1). Prior visits
to primary care units, including otolaryngology clinics, and
antibiotic exposure in the previous 12 months were frequent-
ly present in both groups. No subjects had close contact with
people having these risk factors. 
Identification of MRSA 
All 64 S. aureus strains analyzed were confirmed as MRSA
by the oxacillin disk diffusion method and the presence of a
400-bp mecA gene fragment amplified by PCR.
Antimicrobial susceptibility
All 64 MRSA isolates were resistant to penicillin and ery-
thromycin. The majority of the isolates tested were resistant
to gentamicin (95.6%), tetracycline (94.1%), cephalothin
(92.6%), clindamycin (91.2%), and ciprofloxacin (91.2%),
while all isolates were susceptible to vancomycin. There was
no difference between the initial and the follow-up isolates
in resistance rates to non-β -lactam antibiotics. 
Molecular characterization of MRSA strains 
Genotyping of 64 MRSA isolates showed four sequence
types by MLST and three SCCmec types (II, III, and IV) by
PCR-RFLP-SCCmec typing. The prevalent STs were ST5 (41
strains, 64%) and ST239 (21 strains, 33%), which carried
SCCmec types II and III, respectively (Table 2). There was not
a distinct demarcation of distribution of SCCmec types II and
III between the initial visit and follow-up visit. The only one
isolate from the follow-up visit carried SCCmec type IV. 
Our data identified ST5-MRSA-II and ST239-MRSA-III
as two major genotypes of MRSA isolates from ear discharge,
based on the proposal by Robinson and Enright (8). The
other two genotypes, ST1-MRSA-III and ST72-MRSA-IV,
each were found in one isolate. 
The PFGE analysis of 64 MRSA isolates showed eight
genotypes (A, B, C, D, E, F, G, and H) with subtypes. There
were 7 subtypes in both genotypes A and B, and 3 subtypes
in genotype C. Fifty-three isolates (83%) belonged to the
major genotypes, A (28 isolates) and B (25 isolates). The
distribution and banding patterns of genotypes, according
to the timing of MRSA isolation, are shown in Fig. 1. Geno-
type A was predominant in the initial visit, accounting for
Characteristics
Initial visit*
(n=33)
Follow up visit
�
(n=31)
Age (mean±SD), yr 48.0±17.9 41.7±19.9
median 42 47
Male/female 15/18 10/21
Underlying disease 5 2
Diabetes 2 1
Hypertension 1
Malignancy 2 1
Prior hospitalization or surgery 3 2
Prior visit to primary care units  26 (79%) 21 (68%)
Antibiotics use prior to 12 months 24 (73%) 25 (81%)
Table 1. Epidemiologic characteristics of 64 outpatients with
chronic otitis media according to time of MRSA isolation from
ear discharge 
*, MRSA was isolated from ear discharge when cultured on days of the
first visit to the otolaryngology department; 
� , MRSA was isolated from
ear discharge when cultured on days of follow-up visit in the otolaryn-
gology department.
MRSA, methicillin-resistant Staphylococcus aureus.
SCCmec
type
ST (allelic profile)
Follow up 
visit
(n=31) (%)
Initial visit
(n=33) (%)
II ST5 (1-4-1-4-12-1-10) 24 (73) 17 (55)
III ST239 (2-3-1-1-4-4-3) 8 (24) 13 (42)
ST1 (1-1-1-1-1-1-1) 1 (3) 0
IV ST72 (1-4-1-8-4-4-3) 0 1 (3)
Table 2. Distribution of SCCmec types and sequence types of
MRSA isolates from ear discharge in 64 outpatients with chronic
otitis media according to time of isolation
ST, sequence type; Allelic profile, arcC-aroE-glpF-gmk-pta-tpi-yqiL;
MRSA, methicillin-resistant Staphylococcus aureus; SCCmec, staphy-
lococcal casstte chromosome mec.
Fig. 1. Dendrogram and SmaI-PFGE banding patterns generated
from 8 different PFGE types (A to H) with subtypes of 64 MRSA
isolates. The numbers in the right indicate distribution of PFGE
types based on timing of isolation (the initial visit vs. the follow-up
visit). The scale in the upper left indicates the coefficient of simi-
larity.
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56%, while genotype B was predominant in the follow-up
visit, accounting for 48%. One isolate each of genotype E
and F were found in the initial visit while one isolate each
of genotype G and H were found in the follow-up visit. The
majority of the PFGE types and subtypes in the initial visit
were identified as ST5-MRSA-II and ST239-MRSA-type
III, and there were similar findings in the follow-up visit as
shown in Table 2. 
DISCUSSION
In this study, we investigated the genetic and epidemio-
logic characteristics of the MRSA isolates from ear discharge
of otolaryngology outpatients with chronic otitis media in
order to determine whether these isolates originated from
the community or the hospital. Many patients with MRSA-
positive cultures during the initial visit had healthcare-asso-
ciated risk factors for MRSA acquisition. Additionally, MRSA
isolates from these individuals had a multi-drug resistance
phenotype and were identified as major gentotypes of hos-
pital-acquired strains (ST5-MRSA-II and ST239-MRSA-III).
These characteristics of the MRSA isolates on the initial visit
did not differ from those of MRSA isolates from the follow-
up visit. The resistance patterns to multiple antibiotics are
similar to those of MRSA strains from tertiary-care hospitals,
as previously reported in a nationwide survey in Korea (9).
Genotype ST5-MRSA-II has been reported as a prototype
clone in Korea (10), and ST239-MRSA-III has also been preva-
lent in Korea since 2001 (11). 
In this study, based on the timing of MRSA isolation, these
risk factors were very limited in their ability to distinguish
whether the MRSA was community-acquired or hospital-
acquired. However, these data suggest that MRSA ear car-
riage on the initial visit could be acquired during the visit
to primary care units. In previous studies, it had been report-
ed that non-disposable aurioscope ear pieces were colonized
with pathogenic bacteria, including MRSA, and could be a
potential source of cross-colonization of MRSA among pedi-
atric patients in an ambulatory setting (12). In addition,
empirical antibiotic use and prolonged duration of antibiot-
ic therapy were often cited for increasing bacterial resistance
in primary and secondary otolaryngology care (13). 
Patients with MRSA ear carriage pose unique problems
in terms of treatment. Most of these individuals are asymp-
tomatic from the bacteria but can become infected with the
organisms over time. Moreover, they silently pass the organ-
isms to other uninfected people and can transfer the organ-
isms to other hospitals. Previous studies on MRSA isolates
in the otolaryngology field showed a prevalence of MRSA
only among the isolates from patients with suppurative oti-
tis media in Japan (14) and from patients with chronic rhi-
nosinusitis in the United States (15). Although MRSA iso-
lation has increased among otolaryngology outpatients in
recent years, there is a lack of data to explain how and where
the acquisition of MRSA strains occurs. 
While the data from our study were from a limited num-
ber of MRSA isolates of a Korean University Hospital, the
findings support the theory that MRSA strains spread from
tertiary care hospitals to primary or secondary care units in
the community and then are reintroduced into tertiary care
hospitals. Further studies remain to clarify the spread of noso-
comial MRSA clones into primary or secondary care facilities.
In conclusion, our study indicates that the majority of
MRSA isolates from otolaryngology outpatients with chron-
ic otitis media could be healthcare-associated or hospital-
acquired. This finding suggests that MRSA ear carriage is
one of potential sources of intra- and inter-hospital spread in
Korea. Therefore, we recommend infection control precau-
tions and the judicious use of antibiotics in the practice of
otolaryngology. This is the first report of genetic analysis of
MRSA strains from otolaryngology practices in Korea.
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